Literature DB >> 17100628

In vitro infection of human monocyte-derived dendritic cells with Candida albicans: receptorial involvement and therapeutic implications.

Maria Pepe1, Emilio Jirillo, Vito Covelli.   

Abstract

Nowadays, infections with Candida albicans (C.a.) are very frequent, mostly in the so-called immunocompromised host. Therefore, research has been focused on the types of immune response elicited by C.a., with the aim to develop novel therapeutic strategies. Neutrophils and macrophages (MØ) are deeply involved in the host defense against C.a., and also dendritic cells (DCs) seem to be very active in the host protection. In particular, DCs display an array of surface receptors able to interact with fungal components, even including Toll-like receptors. Here, we will illustrate the in vitro immune response of human monocyte-derived DCs infected with C.a. In this test system, DCs exert phagocytic and killing activities with a magnitude similar to that of MØ. Moreover, in the presence of autologous CD4(+) cells, DCs produce T-helper (h) 1 type cytokines. This Th1 polarizing activity is mediated by interleukin-12 released by infected CDs in the presence of CD4(+) cells. Taken together, these data suggest a protective role played by DCs in the course of C.a. infection and the possibility to develop new strategies of immune intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100628     DOI: 10.2174/138161206778743592

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

Review 1.  Neuroendocrine factors alter host defense by modulating immune function.

Authors:  Cherie L Butts; Esther M Sternberg
Journal:  Cell Immunol       Date:  2008-03-07       Impact factor: 4.868

Review 2.  The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.

Authors:  Xiao-Qing Wei; Helen Rogers; Michael A O Lewis; David W Williams
Journal:  Clin Dev Immunol       Date:  2010-10-24

3.  Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor.

Authors:  Mingyue Wang; Pranab K Mukherjee; Jyotsna Chandra; Ali Abdul Lattif; Thomas S McCormick; Mahmoud A Ghannoum
Journal:  BMC Microbiol       Date:  2008-02-19       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.